Phase Forward has worked with several partners and sponsors in the region for the last seven years to support several hundred hosted clinical trials. While expanding in India, Phase Forward will leverage its successful model of staffing global projects with in-country and external resources.
Bob Weiler, Phase Forward’s CEO and president, said: “The Indian market is strategic to Phase Forward’s continued growth. The formation of a subsidiary in India is a natural extension of our long-established strategy to give our customers access to the most advantageous and cost-effective mix of offshore and onshore resources available. Since India is such a high-growth area for the biopharma services industry, we wanted to expand our commitment to the region by adding our own employees to our partner resources in the region.”
Kris Canekeratne, chairman and CEO of Virtusa, said: “We are pleased with the high-quality partnership we have built with Phase Forward. We are delighted to extend ourselves beyond engineering services to include professional services as well. This is an important step in the evolution of our pharmaceutical practice as it expands the range of services that we offer our pharmaceutical clients.”